Molecularly-targeted therapy of gastric cancer

被引：0
|
作者：
Jeziorski, Krzysztof G. [1 ]
机构：
[1] Inst Marii Sklodowskiej Curie Warszawie, Ctr Onkol, Klinika Nowotworow Ukladu Pokarmowego, Ul Roentgena 5, PL-02781 Warsaw, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2011年 / 7卷 / 05期
关键词：
gastric cancer; targeted therapy; trastuzumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Gastric cancer is a heterogeneous malignancy with expression of many molecular factors. Trastuzumab is the first biologic drug (targeted therapy) that has shown benefits in terms of increased median overall survival. Trastuzumab in combination with chemotherapy is indicated in metastatic gastric or gastrooesophageal junction cancer in patients with no prior exposure to systemic anticancer therapy for disseminated disease and with HER2 protein overexpression (score of IHC 3+) regardless of HER2 gene copy number and with expression of 2+ combined with HER2 gene amplification, although clinical benefits in this group are much less evident.
引用
收藏
页码：258 / 263
页数：6
相关论文
共 50 条
  • [41] Molecularly targeted therapy in breast cancer: The new generation
    Nahleh, Zeina A.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2008, 3 (02) : 100 - 104
  • [42] Oral cancer screening approach based on labeling exfoliated oral cells with molecularly-targeted optical contrast agents
    Leautaud, Veronica
    Horres, Charles R.
    Bhattar, Vijayashree S.
    Williams, Michelle D.
    Gillenwater, Ann M.
    Richards-Kortum, Rebecca R.
    PHOTONIC THERAPEUTICS AND DIAGNOSTICS VII, 2011, 7883
  • [43] Ovarian cancer: molecular pathology and molecularly targeted therapy
    Reis, Henning
    Voelkl, Lisa
    Demes, Melanie
    Moinfar, Farid
    Wild, Peter J. J.
    PATHOLOGIE, 2023, 44 (05): : 320 - 328
  • [44] Assessing bladder hyper-permeability biomarkers in vivo using molecularly-targeted MRI
    Towner, Rheal A.
    Smith, Nataliya
    Saunders, Debra
    Lerner, Megan
    Greenwood-Van Meerveld, Beverley
    Hurst, Robert E.
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 10 (01): : 57 - 65
  • [45] Genomic alterations, molecularly targeted therapy and race: Real world data from the Endometrial Cancer Molecularly Targeted Therapy Consortium
    Secord, Angeles Alvarez
    Pothuri, Bhavana
    Backes, Floor
    Thaker, Premal
    Gehrig, Paola
    Previs, Rebecca
    Borden, Lindsay
    Thomas, Samantha
    Biostatistics, Ms
    Jackson, Amanda
    Konecny, Gottfried
    Duska, Linda
    Arend, Rebecca
    Wright, Jason
    Corr, Bradley
    Maxwell, G. Larry
    Cosgrove, Casey
    Mullen, Mary
    Moore, Kathleen
    Herzog, Thomas
    Cohen, Joshua
    Gockley, Allison
    Gaillard, Stephanie
    Fader, Amanda
    Berchuck, Andrew
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S52 - S53
  • [46] Targeted Therapy for advanced Gastric Cancer
    Pommer, Peter
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (22) : 1604 - 1604
  • [47] Small Molecules in Cancer Therapy: Cytotoxics and Molecularly Targeted Agents
    Blazovics, Anna
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2011, 6 (01) : 2 - 19
  • [48] Oncogene addiction: setting the stage for molecularly targeted cancer therapy
    Sharma, Sreenath V.
    Settleman, Jeffrey
    GENES & DEVELOPMENT, 2007, 21 (24) : 3214 - 3231
  • [49] Molecularly targeted therapy of a patient with clear cell renal cancer
    Czartoryska-Arlukowicz, Bogumila
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 : C1 - C2
  • [50] Future Cancer Therapy with Molecularly Targeted Therapeutics: Challenges and Strategies
    Kim, Mi-Sook
    BIOMOLECULES & THERAPEUTICS, 2011, 19 (04) : 371 - 389
12345